Population pharmacokinetics of vancomycin in Thai patients

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Purwonugroho, Tunggul Adi ^a,b   Chulavatnatol, Suvatna ^a   Preechagoon, Yupaporn ^c   Chindavijak, Busba ^a   Malathum, Kumthorn ^c   Bunuparadah, Pakwan ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JENDERAL SOEDIRMAN UNIVERSITY   (Indonesia)

^c KHON KAEN UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT; CREATININE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; COMPARTMENT MODEL; CREATININE CLEARANCE; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SELECTION; POPULATION RESEARCH; THAILAND; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; URINE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; THAILAND; VANCOMYCIN;

EID: 84861071962     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/762649     Document Type: Article

References (23)

1. Ohnishi A., Yano Y., Shimamura K., Oguma T., Evaluation of Bayesian predictability of vancomycin concentration in patients with various degrees of renal function Biological and Pharmaceutical Bulletin 2001 24 12 1446 1450
2. Matzke G. R., Zhanel G. G., Guay D. R. P., Clinical pharmacokinetics of vancomycin Clinical Pharmacokinetics 1986 11 4 257 282
3. Bauer L. A., Black D. J., Lill J. S., Vancomycin dosing in morbidly obese patients European Journal of Clinical Pharmacology 1998 54 8 621 625
4. Llopis-Salvia P., Jiménez-Torres N. V., Population pharmacokinetic parameters of vancomycin in critically ill patients Journal of Clinical Pharmacy and Therapeutics 2006 31 5 447 454
5. Launay-Vacher V., Izzedine H., Mercadal L., Deray G., Clinical review: use of vancomycin in haemodialysis patients Critical Care 2002 6 4 313 316
6. Yamamoto M., Kuzuya T., Baba H., Yamada K., Nabeshima T., Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type Journal of Clinical Pharmacy and Therapeutics 2009 34 4 473 483
7. Appelbaum P. C., Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA) International Journal of Antimicrobial Agents 2007 30 5 398 408
8. Healy D. P., Polk R. E., Garson M. L., Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers Antimicrobial Agents and Chemotherapy 1987 31 3 393 397
9. Matzke G. R., Kovarik J. M., Rybak M. J., Boike S. C., Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage Clinical Pharmacy 1985 4 3 311 315
10. Moellering R. C. Jr., Krogstad D. J., Greenblatt D. J., Vancomycin therapy in patients with impaired renal function: a nomogram for dosage Annals of Internal Medicine 1981 94 3 343 346
11. Cockcroft D. W., Gault M. H., Prediction of creatinine clearance from serum creatinine Nephron 1976 16 1 31 41
12. Spruill W. J., Wade W. E., Cobb H. H., Estimating glomerular filtration rate with a modification of diet in renal disease equation: implications for pharmacy American Journal of Health-System Pharmacy 2007 64 6 652 660
13. Sheiner L. B., Beal S. L., Some suggestions for measuring predictive performance Journal of Pharmacokinetics and Biopharmaceutics 1981 9 4 503 512
14. Grasela T. H., Sheiner L. B., Pharmacostatistical modeling for observational data Journal of Pharmacokinetics and Biopharmaceutics 1991 19 3
15. Yasuhara M., Iga T., Zenda H., Okumura K., Oguma T., Yano Y., Hori R., Population pharmacokinetics of vancomycin in Japanese adult patients Therapeutic Drug Monitoring 1998 20 2 139 148
16. Mulla H., Pooboni S., Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation British Journal of Clinical Pharmacology 2005 60 3 265 275
17. Cutler N. R., Narang P. K., Lesko L. J., Vancomycin disposition: the importance of age Clinical Pharmacology and Therapeutics 1984 36 6 803 810
18. Hurst A. K., Yoshinaga M. A., Mitani G. H., Foo K. A., Jelliffe R. W., Harrison E. C., Application of a bayesian method to monitor and adjust vancomycin dosage regimens Antimicrobial Agents and Chemotherapy 1990 34 6 1165 1171
19. Rodvold K. A., Blum R. A., Fischer J. H., Zokufa H. Z., Rotschafer J. C., Crossley K. B., Riff L. J., Vancomycin pharmacokinetics in patients with various degrees of renal function Antimicrobial Agents and Chemotherapy 1988 32 6 848 852
20. Del Mar Fernandez De Gatta Garcia M., Revilla N., Calvo M. V., Domnguez-Gil A., Snchez Navarro A., Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients Intensive Care Medicine 2007 33 2 279 285
21. Roberts J. A., Lipman J., Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis Clinical Pharmacokinetics 2006 45 8 756 773
22. Castellano I., Gonzlez Castillo P. M., Covars A., Martnez Snchez J., Surez Santisteban M. A., Gallego S., Marigliano N., Vancomycin dosing in hemodialysis patients Nefrologia 2008 28 6 607 612
23. Rybak M., Lomaestro B., Rotschafer J. C., Moellering R., Craig W., Billeter M., Dalovisio J. R., Levine D. P., Reilly C., Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists American Journal of Health-System Pharmacy 2009 66 1 82 98